Other: fed circuit mandate | Sep 16, 2022 | PAPER | BOARD |
Other: other court decision | Sep 16, 2022 | PAPER | BOARD |
Trial Certificate Checklist | Sep 16, 2022 | PAPER | BOARD |
Patent Owner's Notice of Appeal | Jun 2, 2020 | PAPER | PATENT OWNER |
Termination Decision Document | May 13, 2020 | PAPER | BOARD |
EXPUNGED | May 11, 2020 | PAPER | BOARD |
Hearing Transcript | May 11, 2020 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices | Mar 27, 2020 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notices And Exhibit List | Feb 10, 2020 | PAPER | PETITIONER |
ORDER Oral Hearing 37 C.F.R. ¿¿ 42.70 | Jan 23, 2020 | PAPER | BOARD |
Patent Owner's Updated Mandatory Notices | Jan 14, 2020 | PAPER | PATENT OWNER |
Decision - Granting Patent Owner's Motions for Pro Hac Vice Admission of Jonathan Singer - 37 CFR 42.10 | Jan 10, 2020 | PAPER | BOARD |
Patent Owner's Sur-Reply | Jan 3, 2020 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Argument | Dec 30, 2019 | PAPER | PETITIONER |
Patent Owner's Request for Oral Argument | Dec 30, 2019 | PAPER | PATENT OWNER |
Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Jonathan Singer | Dec 5, 2019 | PAPER | PATENT OWNER |
Declaration of Jonathan Singer | Dec 5, 2019 | EXHIBIT | PATENT OWNER |
Petitioner's Reply to Patent Owner's Response | Nov 22, 2019 | PAPER | PETITIONER |
O'Shaughnessy Deposition Transcript - 10-22-19 - Vol I | Nov 22, 2019 | EXHIBIT | PETITIONER |
Bender LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Pawlowski LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Alarcon LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Wright LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Loesch LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Bibikova LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Chudin LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Kwak LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Godin-Heymann LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Settleman LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Puzanov | Nov 22, 2019 | EXHIBIT | PETITIONER |
Riely | Nov 22, 2019 | EXHIBIT | PETITIONER |
Chen | Nov 22, 2019 | EXHIBIT | PETITIONER |
O'Shaughnessy Deposition Transcript - 10-23-19 - Vol 2 | Nov 22, 2019 | EXHIBIT | PETITIONER |
Spellman Reply Declaration | Nov 22, 2019 | EXHIBIT | PETITIONER |
US Patent No. 9053224 | Nov 22, 2019 | EXHIBIT | PETITIONER |
File History Excerpt for Patent App. No. 12658770 | Nov 22, 2019 | EXHIBIT | PETITIONER |
Penny LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
McGinniss LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Yeakley LinkedIn Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Haber NFCR Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Sordella Cold Spring Harbor Laboratory Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Leyland-Jones NFCR Profile | Nov 22, 2019 | EXHIBIT | PETITIONER |
Gustin | Nov 22, 2019 | EXHIBIT | PETITIONER |
Mittendorf | Nov 22, 2019 | EXHIBIT | PETITIONER |
PANEL CHANGE ORDER
Conduct of the Proceedings
37 C.F.R. ¿¿ 42.5 | Nov 21, 2019 | PAPER | BOARD |
Patent Owner's Updated Mandatory Notices | Oct 18, 2019 | PAPER | PATENT OWNER |
Patent Owner's Updated Power of Attorney | Oct 18, 2019 | PAPER | PATENT OWNER |
Granting Patent Owner's Motions for Pro Hac Vice Admission of Christina Brown-Marshall | Oct 15, 2019 | PAPER | BOARD |
Granting Patent Owner's Motions for Pro Hac Vice Admission of Corrin Drakulich | Oct 15, 2019 | PAPER | BOARD |
Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Corrin Drakulich | Oct 4, 2019 | PAPER | PATENT OWNER |
Declaration of Corrin Drakulich | Oct 4, 2019 | EXHIBIT | PATENT OWNER |
Declaration of Christina Brown-Marshall | Oct 3, 2019 | EXHIBIT | PATENT OWNER |
Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Christina Brown-Marshall | Oct 3, 2019 | PAPER | PATENT OWNER |
Petitioner's Notice of Deposition of Joyce A. O'Shaughnessy, M.D. | Sep 27, 2019 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notices | Sep 18, 2019 | PAPER | PETITIONER |
Decision Granting Petitioner's Motions for Pro Hac Vice Admission of Vinita Ferrera | Sep 18, 2019 | PAPER | BOARD |
Petitioner's Motion For Admission Pro Hac Vice of Vinita Ferrera | Sep 13, 2019 | PAPER | PETITIONER |
Ferrera Declaration | Sep 13, 2019 | EXHIBIT | PETITIONER |
Patent Owner's Response | Aug 30, 2019 | PAPER | PATENT OWNER |
Hanahan, et al., The Hallmarks of Cancer | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
National Comprehensive Cancer Network, Breast Cancer Clinical Practice Guidelines in Oncology | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
National Comprehensive Cancer Network, Non Small Cell Lung Cancer Clinical Practice Guidelines in Oncology Part 1 of 2 | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Leslie A. Pray, Gleevec The Breakthrough in Cancer Treatment | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Deposition Transcript of Paul Spellman PhD Foundation Medicine
V. Caris MPI, Inc. July 25, 2019 | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Expert Declaration of Joyce O¿¿¿Shaughnessy, M.D. | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Dr. Daniel Von Hoff Presented With Top Genomics Award from
Scripps | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Foundation Medicine, Inc., Foundation One Technical Information and Test Overview | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Sorlie, et al., Repeated Observation of Breast Tumor Subtypes in Independent Gene Expression Sets | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
National Comprehensive Cancer Network, Gastric Cancer Clinical Practice Guidelines in Oncology | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
National Comprehensive Cancer Network, Non Small Cell Lung Cancer Clinical Practice Guidelines in Oncology Part 2 of 2 | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
National Comprehensive Cancer Network, Breast Cancer Version
4 2017 Clinical Practice Guidelines in Oncology | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
The Cancer Genome Atlas Research Network et al., The Cancer Genome Atlas Pan Cancer Analysis Project | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Corless et al., Tackling Formalin Fixed, Paraffin Embedded Tumor Tissue with Next Generation Sequencing | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
National Comprehensive Cancer Network, Colon Cancer Version 1 2017 Clinical Practice Guidelines in Oncology | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Gleevec FDA 2001 Approval Letter | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Gleevec FDA 2002 Approval Letter | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Avastin, Highlights of Prescribing Information | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Foundation Medicine, Inc., Form 10K, filed March 3, 2017 for the period ending December 31, 2016 | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Lynch et al., Activating mutation in the epidermal growth factor receptor underlying responsiveness of non small cell lung cancer to gefitinib | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Fuest, Dan Von Hoff's Karnofsky Lecture Smart Phase I Trials Can Extend Life Beyond The Last 12 Weeks | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Richard Simon, Roadmap for Developing and Validating Therapeutically Relevant Genomic Classifiers | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Von Hoff et al., Frequency of Potential Therapeutic Targets Identified by IHC and DNA Microarray in Tumors From Patients Who Have Progressed on Multiple Therapeutic Agents | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
National Comprehensive Cancer Network, Small Cell Lung Cancer Clinical Practice Guidelines in Oncology | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Gleevec Label | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Shen et al., Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing among Patients with Newly Diagnosed Metastatic Lung Cancer | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Paez et al., EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Pao et al., EGF receptor gene mutations are common in lung cancers from¿¿¿never smokers and correlate with sensitivity of tumors to gefitinib (Iressa) and erlotinib (Tarceva) | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Kari et. al, Targeting the Epidermal Growth Factor in Cancer | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Tanner et. al, Amplification of HER 2 in Gastric Carcinoma | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Flavell, Keytruda | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Yang, Epidemiology of Lung Cancer Prognosis Quantity and Quality of Life | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Azzoli et. al, American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non Small Cell Lung Cancer | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Haber et al., Molecular Targeted Therapy of Lung Cancer EGFR Mutations and Response to EGFR Inhibitors | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
F Loupakis et. al, KRAS codon 61 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild type metastatic colorectal cancer | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Sartore Bianch et al., PIK3CA Mutations in Colorectal Cancer Associated with Clinical Resistance to EGFR Targeted Monoclonal Antibodies | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Black et al., Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E Cadherin Expression in Urothelial Carcinoma Cells | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
FoundationOne Liquid Technical Specification | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
FoundationOne HEME Technical Specification | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
FoundationOne CDX Webpage | Aug 30, 2019 | EXHIBIT | PATENT OWNER |
Patent Owner's Cancellation of Deposition | Aug 6, 2019 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Mark Abramovitz, Ph.D | Jul 30, 2019 | PAPER | PATENT OWNER |
Declaration of Sylvia Hall-Ellis, Ph.D. | Jul 29, 2019 | EXHIBIT | PETITIONER |
Joint Stipulation to Modify Due Dates 1-3 | Jul 29, 2019 | PAPER | PATENT OWNER |
Decision Granting Petitioner's Motions for Pro Hac Vice Admission of Shirley X. Li Cantin | Jul 23, 2019 | PAPER | BOARD |
Decision Granting Petitioner's Motions for Pro Hac Vice Admission of David B. Bassett | Jul 23, 2019 | PAPER | BOARD |
Exhibit 3003 | Jul 22, 2019 | EXHIBIT | BOARD |
Granting Petitioner's Motion to File Supplemental Information | Jul 22, 2019 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices | Jul 19, 2019 | PAPER | PETITIONER |
ORDER Conduct of the Proceeding | Jul 15, 2019 | PAPER | BOARD |
Exhibit 3002 | Jul 15, 2019 | EXHIBIT | BOARD |
Corrected Affidavit of Christopher Butler | Jul 15, 2019 | EXHIBIT | PETITIONER |
Petitioners Motion For Admission Pro Hac Vice Of David B. Bassett | Jul 3, 2019 | PAPER | PETITIONER |
Declaration Of David B. Bassett In Support Of Motion For Admission Pro Hac Vice | Jul 3, 2019 | EXHIBIT | PETITIONER |
Petitioners Motion For Admission Pro Hac Vice Of Shirley X. Li Cantin | Jul 3, 2019 | PAPER | PETITIONER |
Declaration Of Shirley X. Li Cantin In Support Of Motion For Admission Pro Hac Vice | Jul 3, 2019 | EXHIBIT | PETITIONER |
Patent Owner's Opposition to Petitioner's Motion to Submit Supplemental Information | Jul 1, 2019 | PAPER | PATENT OWNER |
Motion to Submit Supplemental Information | Jun 24, 2019 | PAPER | PETITIONER |
Declaration of Mark Abramovitz | Jun 24, 2019 | EXHIBIT | PETITIONER |
Mark Abramovitz et al. | Jun 24, 2019 | EXHIBIT | PETITIONER |
Jian-Bing Fan et al. | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
Bio-It World | Jun 24, 2019 | EXHIBIT | PETITIONER |
Illumina Seminar Notice | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
Sunnybrook Seminar Notice | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
EXPUNGED | Jun 24, 2019 | EXHIBIT | PETITIONER |
Order - Conduct of the Proceedings - 37 CFR 42.5 | Jun 18, 2019 | PAPER | BOARD |
Notice of Deposition of Paul T. Spellman, Ph.D | Jun 17, 2019 | PAPER | PATENT OWNER |
Patent Owner's Objections to Evidence | May 28, 2019 | PAPER | PATENT OWNER |
Trial Instituted Document | May 14, 2019 | PAPER | BOARD |
Scheduling Order | May 14, 2019 | PAPER | BOARD |
PANEL CHANGE ORDER
Conduct of the Proceedings
37 C.F.R. ¿¿ 42.5 | Apr 8, 2019 | PAPER | BOARD |
Patent Owner's Sur-reply to Petitioner's Reply | Mar 19, 2019 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owner's Preliminary Response | Mar 12, 2019 | PAPER | PETITIONER |
Conduct of the Proceeding | Mar 5, 2019 | PAPER | BOARD |
Ex. 3001 | Mar 4, 2019 | EXHIBIT | BOARD |
Horstmann, et al Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002 | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
Declaration of Michael Castro, submitted during prosecution of U.S. Patent App. 11/750,721 | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
Patent Owner's Preliminary Response | Feb 15, 2019 | PAPER | PATENT OWNER |
Wakelee, et al Optimizing First-Line Treatment Options for Patience with Advanced NSCLC | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
Benson, et al American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
Declaration of Sandeep K. Reddy, submitted during prosecution of U.S. Patent App. 14/249,261 | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 8,880,350 | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 9,372,193 | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
U.S. Patent No. 9,383,365 | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
Von Hoff, Pilot Study Using Molecular Profiling of Patients Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
National Comprehensive Cancer Network, Breast Cancer Clinical Practice Guidelines in Oncology | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
Leyland-Jones, Trastuzumab: Hopes and Realities | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
National Comprehensive Cancer Network, Colon Cancer Clinical Practice Guidelines in Oncology | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
Seena Magowitz Foundation, Dr. Daniel Von Hoff Wins ASCO Award | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
Doroshow, et al. Selecting Systemic Cancer Therapy One Patient at a Time Is There a Role for Molecular Profiling of Individual Patients With Advanced Solid Tumors? | Feb 15, 2019 | EXHIBIT | PATENT OWNER |
Patent Owner's Power of Attorney | Nov 19, 2018 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | Nov 19, 2018 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Nov 16, 2018 | PAPER | BOARD |
U.S. Patent No. 9,292,660 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Lu | Nov 6, 2018 | EXHIBIT | PETITIONER |
Muraca | Nov 6, 2018 | EXHIBIT | PETITIONER |
McDoniels-Silvers | Nov 6, 2018 | EXHIBIT | PETITIONER |
Power of Attorney | Nov 6, 2018 | PAPER | PETITIONER |
Illumina Gene Expression Profiling | Nov 6, 2018 | EXHIBIT | PETITIONER |
Langreth | Nov 6, 2018 | EXHIBIT | PETITIONER |
NHGRI Seeks Next Generation | Nov 6, 2018 | EXHIBIT | PETITIONER |
Genomics and Personalized Medicine Act | Nov 6, 2018 | EXHIBIT | PETITIONER |
Gibbs | Nov 6, 2018 | EXHIBIT | PETITIONER |
Iqbal | Nov 6, 2018 | EXHIBIT | PETITIONER |
Herceptin Prescribing Information | Nov 6, 2018 | EXHIBIT | PETITIONER |
Scholl | Nov 6, 2018 | EXHIBIT | PETITIONER |
Iressa Prescribing Information | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sawyers | Nov 6, 2018 | EXHIBIT | PETITIONER |
Gleevec Prescribing Information | Nov 6, 2018 | EXHIBIT | PETITIONER |
Tarceva Prescribing Information | Nov 6, 2018 | EXHIBIT | PETITIONER |
Xiong | Nov 6, 2018 | EXHIBIT | PETITIONER |
Erbitux (cetuximab) Prescribing Information (Feb. 12, 2004) | Nov 6, 2018 | EXHIBIT | PETITIONER |
Butler Affidavit | Nov 6, 2018 | EXHIBIT | PETITIONER |
Moyer | Nov 6, 2018 | EXHIBIT | PETITIONER |
Study of TARCEVA | Nov 6, 2018 | EXHIBIT | PETITIONER |
NCI Drug Dictionary cetuximab | Nov 6, 2018 | EXHIBIT | PETITIONER |
Erbitux (cetuximab) Prescribing Information (Mar. 1, 2006) | Nov 6, 2018 | EXHIBIT | PETITIONER |
Staunton | Nov 6, 2018 | EXHIBIT | PETITIONER |
Butte | Nov 6, 2018 | EXHIBIT | PETITIONER |
Daly | Nov 6, 2018 | EXHIBIT | PETITIONER |
Jarvie | Nov 6, 2018 | EXHIBIT | PETITIONER |
Rhodes Oncomine: A Cancer Microarray Database | Nov 6, 2018 | EXHIBIT | PETITIONER |
Rhodes Large-scale meta-analysis | Nov 6, 2018 | EXHIBIT | PETITIONER |
Gollub | Nov 6, 2018 | EXHIBIT | PETITIONER |
Statnikov | Nov 6, 2018 | EXHIBIT | PETITIONER |
Zheng | Nov 6, 2018 | EXHIBIT | PETITIONER |
Rhodes Oncomine 3.0 Neoplasia | Nov 6, 2018 | EXHIBIT | PETITIONER |
Parkinson ArrayExpress | Nov 6, 2018 | EXHIBIT | PETITIONER |
Forbes COSMIC 2005 | Nov 6, 2018 | EXHIBIT | PETITIONER |
U.S. Provisional Patent Application No. 60/747,645 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Oxford Dictionary of Biochemistry and Molecular Biology | Nov 6, 2018 | EXHIBIT | PETITIONER |
HUGO EGFR | Nov 6, 2018 | EXHIBIT | PETITIONER |
Business Wire | Nov 6, 2018 | EXHIBIT | PETITIONER |
Bibikova Gene Expression Profiles | Nov 6, 2018 | EXHIBIT | PETITIONER |
Fan Versatile Assay | Nov 6, 2018 | EXHIBIT | PETITIONER |
Chen TTD: Therapeutic Target Database | Nov 6, 2018 | EXHIBIT | PETITIONER |
Lamb The Connectivity Map | Nov 6, 2018 | EXHIBIT | PETITIONER |
Hughes Functional Discovery | Nov 6, 2018 | EXHIBIT | PETITIONER |
Zhao Homozygous Deletions | Nov 6, 2018 | EXHIBIT | PETITIONER |
HUGO ERBB2 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Bibikova Quantitative Gene Expression Profiling | Nov 6, 2018 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,092,392 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Moore Prototype Internet | Nov 6, 2018 | EXHIBIT | PETITIONER |
HUGO CASP8 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Febbo Personalized diagnostic | Nov 6, 2018 | EXHIBIT | PETITIONER |
HUGO ESR1 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Xie 2005 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Gnirke | Nov 6, 2018 | EXHIBIT | PETITIONER |
Ley 2008 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sugarbaker | Nov 6, 2018 | EXHIBIT | PETITIONER |
Katoh Bioinformatics for Cancer Management | Nov 6, 2018 | EXHIBIT | PETITIONER |
Stipp Gene Chip Breakthrough | Nov 6, 2018 | EXHIBIT | PETITIONER |
Fan BeadArray | Nov 6, 2018 | EXHIBIT | PETITIONER |
Wishart | Nov 6, 2018 | EXHIBIT | PETITIONER |
Egan Monitoring Patients | Nov 6, 2018 | EXHIBIT | PETITIONER |
NIH National Cancer Institute | Nov 6, 2018 | EXHIBIT | PETITIONER |
Dreifus Researcher Behind the Drug Gleevec | Nov 6, 2018 | EXHIBIT | PETITIONER |
Longo, Imatinib Changed Everything | Nov 6, 2018 | EXHIBIT | PETITIONER |
Cappuzzo | Nov 6, 2018 | EXHIBIT | PETITIONER |
Complaint | Nov 6, 2018 | EXHIBIT | PETITIONER |
Samuels | Nov 6, 2018 | EXHIBIT | PETITIONER |
Gautam | Nov 6, 2018 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2008/0014146 | Nov 6, 2018 | EXHIBIT | PETITIONER |
U.S. Patent No 8,768,629 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Wang Discrepancy between mRNA | Nov 6, 2018 | EXHIBIT | PETITIONER |
HUGO RAF1 | Nov 6, 2018 | EXHIBIT | PETITIONER |
U.S. Provisional Application No. 61/217,289 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Gnirke Solution hybrid selection | Nov 6, 2018 | EXHIBIT | PETITIONER |
Bardelli | Nov 6, 2018 | EXHIBIT | PETITIONER |
ThermoFisher Scientific Overview of Immunohistochemistry | Nov 6, 2018 | EXHIBIT | PETITIONER |
HUGO PIK3CA | Nov 6, 2018 | EXHIBIT | PETITIONER |
HUGO CTNNB1 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Bepler | Nov 6, 2018 | EXHIBIT | PETITIONER |
HUGO BRAF | Nov 6, 2018 | EXHIBIT | PETITIONER |
U.S. Provisional Application No. 61/105,335 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sjoblom 2006 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sjoblom Table S1 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sjoblom Tables S2A and S2B | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sjoblom Table S6 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Morozova | Nov 6, 2018 | EXHIBIT | PETITIONER |
U.S. Provisional Application No. 61/170,565 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sjoblom 2006 Supporting Material | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sjoblom Table S3 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sjoblom Table S4 | Nov 6, 2018 | EXHIBIT | PETITIONER |
Sjoblom Table S5 | Nov 6, 2018 | EXHIBIT | PETITIONER |
14/187015 File History | Nov 6, 2018 | EXHIBIT | PETITIONER |
KIT Symbol Report | Nov 6, 2018 | EXHIBIT | PETITIONER |
KRAS Symbol Report | Nov 6, 2018 | EXHIBIT | PETITIONER |
Ross Integration of Molecular Diagnostics | Nov 6, 2018 | EXHIBIT | PETITIONER |
Fee Authorization | Nov 6, 2018 | PAPER | PETITIONER |
Spellman Declaration | Nov 6, 2018 | EXHIBIT | PETITIONER |
Petition for Inter Partes Review of U.S. Patent No. 9,292,660 | Nov 6, 2018 | PAPER | PETITIONER |